A detailed history of Advantage Alpha Capital Partners LP transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 82,883 shares of MDXG stock, worth $769,154. This represents 0.12% of its overall portfolio holdings.

Number of Shares
82,883
Previous 126,592 34.53%
Holding current value
$769,154
Previous $877,000 44.24%
% of portfolio
0.12%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.65 - $7.76 $246,955 - $339,181
-43,709 Reduced 34.53%
82,883 $489,000
Q2 2024

Aug 13, 2024

SELL
$6.16 - $8.08 $81,934 - $107,472
-13,301 Reduced 9.51%
126,592 $877,000
Q1 2024

May 13, 2024

SELL
$7.61 - $8.63 $135,549 - $153,717
-17,812 Reduced 11.29%
139,893 $1.08 Million
Q4 2023

Feb 13, 2024

BUY
$5.7 - $9.14 $898,918 - $1.44 Million
157,705 New
157,705 $1.38 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Advantage Alpha Capital Partners LP Portfolio

Follow Advantage Alpha Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.